QIFENDA
Live / Registered — Registered (as of 25 Oct 2022)
What this means for you
Registered since 25 Oct 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90897703
- Registration number
- 6883231
- Mark type
- Stylized text
- Filed
- 23 Aug 2021
- Published for opposition
- 09 Aug 2022
- Registered
- 25 Oct 2022
- Attorney of record
- Michael G Shariff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, in the form of pills and liquid oral spray, for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; all purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores
Owner
- AIPHARMA DEVELOPMENT LLC, Dubai, DE, US
- AIPHARMA DEVELOPMENT LLC, Dubai, DE, US
- AIPHARMA DEVELOPMENT LLC, Dubai, DE, US
- AiPharma Asia Limited, Tsim Sha Tsui, Kowloon, HK
Prosecution history
- 25 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 09 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Aug 2022 — PUBLISHED FOR OPPOSITION
- 20 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Jul 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Jun 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Jun 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Jun 2022 — ASSIGNED TO LIE
- 17 Jun 2022 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 15 Jun 2022 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 15 Jun 2022 — FINAL REFUSAL E-MAILED
- 15 Jun 2022 — FINAL REFUSAL WRITTEN
- 06 Jun 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Jun 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE